mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.3 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |